Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

New York, Jan 7, 2026, 12:23 (EST) — Regular session

  • Mastercard shares up about 0.7% near midday, outperforming Visa
  • Morgan Stanley kept an “overweight” view, highlighting cross-border fees and security-led services growth
  • Traders are watching Friday’s U.S. jobs report and Mastercard’s Jan. 9 dividend record date

Mastercard Incorporated (NYSE:MA) shares rose 0.7% to $584.60 on Wednesday, after trading between $577.52 and $584.60. About 1.36 million shares had changed hands by late morning.

The move came in a mixed session for U.S. stocks. The S&P 500-tracking SPY was up about 0.3% while the Dow-linked DIA slipped 0.1%; tech-heavy QQQ gained about 0.7%.

Labor data kept risk appetite in check ahead of Friday’s government jobs report. U.S. private payrolls rose 41,000 in December, below economists’ forecasts, ADP data showed.

Morgan Stanley kept Mastercard rated “overweight” — a call that signals it expects the stock to outperform others in its coverage. Analysts including James Faucette pointed to steady U.S. spending and strength in cross-border activity, higher-fee purchases when cardholders spend outside their home country, and faster growth in value-added services such as fraud tools.

Visa shares slipped about 0.4% in midday trade. Investors often treat Visa and Mastercard as a paired bet on card spending, though Mastercard’s larger cross-border mix can make it more sensitive to shifts in travel and international e-commerce.

Still, a long-running fight over U.S. “swipe fees” — the charges merchants pay to accept card payments — remains a shadow for the sector. Consumer and small-business groups this week faulted a proposed settlement involving Visa and Mastercard, after the networks announced a revised $38 billion deal with merchants in November.

Mastercard jumped 2.1% on Tuesday to close at $580.34 and is still about 3.6% below its 52-week high of $601.77, MarketWatch data showed. Tuesday’s volume ran above its 50-day average, the report said.

The company’s dividend is also on some trading desks’ calendars. Mastercard declared an 87-cent quarterly payout with a Jan. 9 record date and a Feb. 9 payment date, according to its investor-relations site.

Next up is the U.S. nonfarm payrolls report on Friday at 8:30 a.m. ET, followed by the December consumer price index on Jan. 13. Those prints could reset bets on interest rates — and, by extension, the tone for consumer-linked stocks such as Mastercard. Bureau of Labor Statistics

Stock Market Today

  • REGN crosses above average 12-month target; shares trade at $820
    January 8, 2026, 7:11 AM EST. Regeneron Pharmaceuticals (REGN) shares rose to $820.00, topping the consensus 12-month target of $816.30 set by analysts. When a target is reached, analysts typically reassess: downgrade on valuation or lift targets on improving fundamentals. The Zacks coverage universe spans 20 targets; the average hides a wide range, from a low $605.00 to a high $970.00, with a standard deviation of $87.334. The move highlights the wisdom of crowds in pricing, inviting investors to judge whether $816.30 represents ongoing upside or a stretched level. Ratings show Strong Buy or Buy signals outweighing Hold and Sell signals, with an average rating of 1.68 on a 1 (Strong Buy) to 5 (Strong Sell) scale. Source: Zacks via Quandl.
Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom
Previous Story

Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target
Next Story

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

Go toTop